Directorate Change

RNS Number:1873M
Lombard Medical PLC
11 June 2003

For immediate release

11 June 2003

                              Lombard Medical plc

                                 Re-Directorate



Following valid acceptances of the Offer by British Linen Advisers Limited on
behalf of Advanced Medical Technologies PLC ("AMT") for Lombard Medical PLC ("
Lombard") by Lombard shareholders owning over 75% of the existing issued share
capital of Lombard, the following persons resigned as directors of Lombard on 9
June 2003:



Alistair H Taylor;

John W E Kerslake;

Alfred J Elbrick;

Dr. William D Potter; and

Steven J Terry.



On 9 June 2003, Antony Barry Bertram Canning (aged 55) and Simon John Stock
(aged 49), both directors of AMT, were each appointed directors of Lombard.



Tony Canning is currently a director of the following companies:  Advanced
Medical Technologies plc, Lion Capital Partners Limited, Bentleigh Cross
Limited, Groundwise Searches Limited, Ummagamma Limited, Lion Capital Partners
PLC, Cougar Developments Limited, Lion Capital Investors Limited, Tiger Estate
Limited, Cougar Estates Limited, Milecrest Ventures Limited, Frametoken Limited
and Schools Plus Limited.



Tony Canning has been a director of the following companies during the past 5
years:  Ixworth Partners Limited, Capitol Taverns Limited, Capitol Securities
Limited, LCA Operations Limited, Carserve Limited and Advicelight Limited.



Tony Canning was a director of the following companies (and certain of their
subsidiaries) when they went into administrative receivership in 1992:
Corporate Communications plc and Charles Barker Limited.



Simon Stock is currently a director of the following companies:  Advanced
Medical Technologies plc, Lion Capital Advisers Limited, Bentleigh Cross
Limited, Lion Capital Partners PLC, Blue Anchor Enterprises Limited and eMuse
Corporation plc (alternate director).



Save as disclosed in this announcement, no further information in relation to
Messrs Canning and Stock falls to be disclosed under paragraph (f) of Schedule 2
of the AIM Rules.





Enquiries:



Christopher Stainforth                     020 7459 3600

Chairman of the Independent Board

Lombard Medical plc



Richard Swindells            020 459 3600

Durlacher Limited

Nominated Adviser to Lombard


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOADGGMVGMLGFZM